P2RX4 and multiple sclerosis: However, in EAE (an animal model of multiple sclerosis, which is another chronic inflammatory disease of the brain and spinal cord), the blockade of P2RX4 signaling exacerbates clinical signs, favors microglial activation to a pro-inflammatory phenotype, and inhibits myelin phagocytosis.